Context Expression and activity of the main lipogenic enzymes is paradoxically decreased in obesity, but the mechanisms behind these findings are poorly known. Breast Cancer 1 (BrCa1) interacts with acetyl-CoA carboxylase (ACC) reducing the rate of fatty acid biosynthesis. In this study, we aimed to evaluate BrCa1 in human adipose tissue according to obesity and insulin resistance, and in vitro cultured adipocytes. Research Design and Methods BrCa1 gene expression, total and phosphorylated (P-) BrCa1, and ACC were analyzed in adipose tissue samples obtained from a total sample of 133 subjects. BrCa1 expression was also evaluated during in vitro differentiation of human adipocytes and 3T3-L1 cells. Results BrCa1 gene expression was significantly up-regulated in both omental (OM; 1.36-fold, p = 0.002) and subcutaneous (SC; 1.49-fold, p = 0.001) adipose tissue from obese subjects. In parallel with increased BrCa1 mRNA, P-ACC was also up-regulated in SC (p = 0.007) as well as in OM (p = 0.010) fat from obese subjects. Consistent with its role limiting fatty acid biosynthesis, both BrCa1 mRNA (3.5-fold, p<0.0001) and protein (1.2-fold, p = 0.001) were increased in pre-adipocytes, and decreased during in vitro adipogenesis, while P-ACC decreased during differentiation of human adipocytes (p = 0.005) allowing lipid biosynthesis. Interestingly, BrCa1 gene expression in mature adipocytes was restored by inflammatory stimuli (macrophage conditioned medium), whereas lipogenic genes significantly decreased. Conclusions The specular findings of BrCa1 and lipogenic enzymes in adipose tissue and adipocytes reported here suggest that BrCa1 might help to control fatty acid biosynthesis in adipocytes and adipose tissue from obese subjects.
References
[1]
Mobbs CV, Makimura H (2002) Block the FAS, lose the fat. Nat Med 8: 335–336.
[2]
Wakil SJ, Stoops JK, Joshi VC (1983) Fatty acid synthesis and its regulation. Annu Rev Biochem 52: 537–579.
[3]
Brownsey RW, Boone AN, Elliott JE, Kulpa JE, Lee WM (2006) Regulation of acetyl-CoA carboxylase. Biochem Soc Trans 34: 223–227.
[4]
Mayas MD, Ortega FJ, Gomez-Huelgas R, Roca N, Fernandez-Real JM, et al. (2009) Decrease in FASN expression in adipose tissue of hypertensive individuals. Am J Hypertens 22: 1258–1262.
[5]
Minehira K, Vega N, Vidal H, Acheson K, Tappy L (2004) Effect of carbohydrate overfeeding on whole body macronutrient metabolism and expression of lipogenic enzymes in adipose tissue of lean and overweight humans. Int J Obes Relat Metab Disord 28: 1291–1298.
[6]
Ortega FJ, Mayas D, Moreno-Navarrete JM, Catalan V, Gomez-Ambrosi J, et al. (2010) The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 18: 13–20.
[7]
Ortega FJ, Vazquez-Martin A, Moreno-Navarrete JM, Bassols J, Rodriguez-Hermosa J, et al. (2009) Thyroid hormone responsive Spot 14 increases during differentiation of human adipocytes and its expression is down-regulated in obese subjects. Int J Obes (Lond).
[8]
Ranganathan G, Unal R, Pokrovskaya I, Yao-Borengasser A, Phanavanh B, et al. (2006) The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment. J Lipid Res 47: 2444–2450.
[9]
Brook CG, Lloyd JK, Wolf OH (1972) Relation between age of onset of obesity and size and number of adipose cells. Br Med J 2: 25–27.
[10]
Knittle JL, Timmers K, Ginsberg-Fellner F, Brown RE, Katz DP (1979) The growth of adipose tissue in children and adolescents. Cross-sectional and longitudinal studies of adipose cell number and size. J Clin Invest 63: 239–246.
[11]
Roncari DA, Lau DC, Kindler S (1981) Exaggerated replication in culture of adipocyte precursors from massively obese persons. Metabolism 30: 425–427.
[12]
Avram MM, Avram AS, James WD (2007) Subcutaneous fat in normal and diseased states 3. Adipogenesis: from stem cell to fat cell. J Am Acad Dermatol 56: 472–492.
[13]
Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ (2001) The biology of white adipocyte proliferation. Obes Rev 2: 239–254.
[14]
Fajas L (2003) Adipogenesis: a cross-talk between cell proliferation and cell differentiation. Ann Med 35: 79–85.
[15]
Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, et al. (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56: 1517–1526.
[16]
Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444: 860–867.
[17]
Ferre P, Foufelle F (2007) SREBP-1c transcription factor and lipid homeostasis: clinical perspective. Horm Res 68: 72–82.
[18]
Nathanson KL, Wooster R, Weber BL (2001) Breast cancer genetics: what we know and what we need. Nat Med 7: 552–556.
[19]
Wang B, Matsuoka S, Ballif BA, Zhang D, Smogorzewska A, et al. (2007) Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316: 1194–1198.
[20]
Bernard-Gallon DJ, De Latour MP, Sylvain V, Vissac C, Aunoble B, et al. (2001) Brca1 and Brca2 protein expression patterns in different tissues of murine origin. Int J Oncol 18: 271–280.
[21]
Lane TF, Deng C, Elson A, Lyu MS, Kozak CA, et al. (1995) Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev 9: 2712–2722.
[22]
Marquis ST, Rajan JV, Wynshaw-Boris A, Xu J, Yin GY, et al. (1995) The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11: 17–26.
[23]
Gowen LC, Johnson BL, Latour AM, Sulik KK, Koller BH (1996) Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat Genet 12: 191–194.
[24]
Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, et al. (1996) The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85: 1009–1023.
[25]
Liu CY, Flesken-Nikitin A, Li S, Zeng Y, Lee WH (1996) Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 10: 1835–1843.
[26]
Magnard C, Bachelier R, Vincent A, Jaquinod M, Kieffer S, et al. (2002) BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains. Oncogene 21: 6729–6739.
[27]
Ray H, Moreau K, Dizin E, Callebaut I, Venezia ND (2006) ACCA phosphopeptide recognition by the BRCT repeats of BRCA1. J Mol Biol 359: 973–982.
[28]
Ray H, Suau F, Vincent A, Dalla Venezia N (2009) Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex. Biochem Biophys Res Commun 378: 615–619.
[29]
Brunet J, Vazquez-Martin A, Colomer R, Grana-Suarez B, Martin-Castillo B, et al. (2008) BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer. Mol Carcinog 47: 157–163.
[30]
Moreau K, Dizin E, Ray H, Luquain C, Lefai E, et al. (2006) BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase. J Biol Chem 281: 3172–3181.
[31]
Shen Y, Tong L (2008) Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1. Biochemistry 47: 5767–5773.
[32]
McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, et al. (2007) Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. Diabetologia 50: 1707–1715.
[33]
Goossens GH (2008) The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94: 206–218.
[34]
Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761–1772.
[35]
Moreno-Navarrete JM, Ortega FJ, Ricart W, Fernandez-Real JM (2009) Lactoferrin increases (172Thr)AMPK phosphorylation and insulin-induced (p473Ser)AKT while impairing adipocyte differentiation. Int J Obes (Lond) 33: 991–1000.
[36]
Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, et al. (2002) Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J Biol Chem 277: 19353–19357.
[37]
Sekiya M, Yahagi N, Matsuzaka T, Takeuchi Y, Nakagawa Y, et al. (2007) SREBP-1-independent regulation of lipogenic gene expression in adipocytes. J Lipid Res 48: 1581–1591.
[38]
Blackshear PE, Goldsworthy SM, Foley JF, McAllister KA, Bennett LM, et al. (1998) Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene 16: 61–68.
[39]
Xu X, Wagner KU, Larson D, Weaver Z, Li C, et al. (1999) Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 22: 37–43.
[40]
Swierczynski J, Zabrocka L, Goyke E, Raczynska S, Adamonis W, et al. (2003) Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans. Mol Cell Biochem 254: 55–59.
[41]
Miettinen TA, Tilvis RS (1981) Cholesterol synthesis and storage in adipose tissue. Int J Obes 5: 613–618.
[42]
Smith J, Al-Amri M, Dorairaj P, Sniderman A (2006) The adipocyte life cycle hypothesis. Clin Sci (Lond) 110: 1–9.
[43]
Bae I, Fan S, Meng Q, Rih JK, Kim HJ, et al. (2004) BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 64: 7893–7909.
[44]
Hjartaker A, Langseth H, Weiderpass E (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630: 72–93.
[45]
Deurenberg P, van der Kooy K, Leenen R, Weststrate JA, Seidell JC (1991) Sex and age specific prediction formulas for estimating body composition from bioelectrical impedance: a cross-validation study. Int J Obes 15: 17–25.
[46]
Fernandez-Real JM, Broch M, Ricart W, Casamitjana R, Gutierrez C, et al. (1998) Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47: 1757–1762.
[47]
Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C (2008) Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45: 115–120.
